https://www.selleckchem.com/pr....oducts/2-deoxy-d-glu
001 for each) except maximal flow rate (Qmax) value (P ˃.05). These results have demonstrated the significant improvements both on voiding and urodynamic parameters under PTNS treatment with a tapering protocol for during 24-months in Parkinson's disease with detrusor activity. These results have demonstrated the significant improvements both on voiding and urodynamic parameters under PTNS treatment with a tapering protocol for during 24-months in Parkinson's disease with detrusor activity. To describe opioid prescribing patte
Like
Comment
Share
